文献速递外周动脉疾病

膝下动脉腔内血运重建策略的贝叶斯网络荟萃分析:伤口血供与angiosome理论的比较

Bayesian network meta-analysis and systematic review of endovascular revascularization strategies for infrapopliteal arteries in chronic limb-threatening ischemia.
PubMed 文献 · J Vasc Surg · 2026-01-21

结果显示DR与IRc在伤口愈合率、无截肢生存率和保肢率上相当且均优于IR;伤口充血(WB)阳性者临床结局更优。

要点

  • DR与IRc在伤口愈合率、无截肢生存率和保肢率上疗效相当,均优于IR。
  • WB阳性患者伤口愈合率、保肢率和无截肢生存率显著更高,保肢获益持续超过3年。
  • DR可能增加WB阳性的可能性,提示术中关注伤口微循环有助于决策。

核心结论

  • 对于慢性威胁肢体缺血的腔内治疗,DR和IRc在三个终点上疗效相当且均优于IR。
  • WB反映伤口微循环,可能更好地指导术中决策并预测良好临床结局。

研究设计与样本

  • 采用贝叶斯网络荟萃分析比较DR、IR和IRc,并综述WB相关文献。

主要发现

  • DR在3、6、12个月及总体分析的伤口愈合率(WHR)上显著优于IR,IRc在12个月及总体分析中显著优于IR。
  • WHR的累积排序曲线下面积(SUCRA)显示DR在术后3、6、12个月排名最高,IRc在6个月、12个月及总体分析与DR相当。
  • 无截肢生存率(AFS)方面,DR在6个月、12个月及总体分析中显著优于IR。
  • 保肢率(LSR)分析显示DR和IRc在12个月及总体分析中均显著优于IR,DR与IRc的SUCRA值相似且高于IR。
  • WB+组相比WB-组的WHR、LSR和AFS显著更高,LSR获益持续超过3年,两组DR/IR比例无显著差异,但WB+组DR患者比例更高。

临床怎么用

  • 膝下动脉腔内血运重建时,优先考虑直接血运重建(DR)或经侧支间接血运重建(IRc),而非单纯间接血运重建(IR)。
  • 术中可评估伤口充血(WB)以反映伤口微循环,辅助决策并预测临床结局。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In 2024, several researchers introduced the concept of "woundosome" in an editorial, highlighting the need to prioritize perfusion and microcirculation function within patient wound areas. Building upon this foundation, we systematically compared this concept with the previously established angiosome theory. METHODS: A comprehensive search was performed across the Cochrane Central Register of Controlled Trials, Embase, and PubMed. Twenty-five relevant studies met the inclusion criteria, including four investigations using wound blush (WB). We implemented a Bayesian network meta-analysis to evaluate angiosome-related studies and reviewed the literature on WB. Within the framework of the network meta-analysis, therapeutic efficacy was compared among direct revascularization (DR), indirect revascularization (IR), and indirect revascularization with collateral vessels (IRc). Primary outcome measures encompassed wound healing rate (WHR), amputation-free survival (AFS), and limb salvage rate (LSR). RESULTS: The network meta-analysis revealed that DR was significantly better than IR in WHR outcomes at 3, 6, and 12 months, as well as in the overall analysis. In addition, IRc demonstrated a significant advantage over IR in both the 12-month and overall analyses. The surface under the cumulative ranking curves (SUCRA) values for WHR indicated that DR achieved the highest ranking at 3, 6, and 12 months after surgery. IRc SUCRA values at 6 months, 12 months, and in the overall analysis were comparable to those of DR. In terms of AFS, DR showed significantly better results than IR at 6 months, 12 months, and in the overall analysis. LSR analysis indicated that both DR and IRc were significantly superior to IR at 12 months and in the overall analysis. The SUCRA curves for AFS and LSR revealed that DR and IRc had similar SUCRA values and higher compared with IR. In the second part of the study, we reviewed research related to WB. Our findings indicated that WHR, LSR, and AFS were significantly higher in the WB+ group compared with the WB- group. The benefit of LSR in WB+ patients persisted for over 3 years, whereas there was no significant difference in DR/IR between the two groups. Notably, the proportion of DR patients in the WB+ group was higher than that in the WB- group, suggesting that DR may increase the likelihood of WB+. CONCLUSIONS: For endovascular treatment of critical limb-threatening ischemia disease, DR and IRc exhibit comparable efficacy across all three end points and are both superior to IR. WB reflects a focus on wound microcirculation and appears to better inform intraoperative decision-making and predict favorable clinical outcomes.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Guo Z, Guo J, Wu S, et al. Bayesian network meta-analysis and systematic review of endovascular revascularization strategies for infrapopliteal arteries in chronic limb-threatening ischemia. J Vasc Surg. 2026. PMID: 41577087. doi:10.1016/j.jvs.2025.12.355

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。